Breast cancer is the second leading cause of death for women worldwide. While
monotherapy (single agent) treatments have been used for many years, they are not always …

Triple-negative breast cancers (TNBC) comprise biologically and clinically heterogeneous
diseases characterized by the lack of hormone receptors (HR) and HER2 expression. This …

Necroptosis is a caspase-independent form of programmed cell death. Receptor interacting
protein kinase 1 (RIPK1) is a key molecule in the initiation of necroptosis and the formation …

In recent years, triple‐negative breast cancer (TNBC) has emerged as the most aggressive
subtype of breast cancer and is usually associated with increased mortality worldwide. The …

Triple-negative breast cancer (TNBC) is a heterogeneous malignancy in women. It is
associated with poor prognosis, aggressive malignant behavior, and limited treatment …

Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type
tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged …

Abstract Triple Negative Breast Cancer (TNBC) is an aggressive tumour with patients
survival rarely exceeding five years. TNBC tumours are larger in size, more chemoresistant …

Background: Triple-negative breast cancer (TNBC) is a great threat to global women's health
due to its high metastatic potential. Epithelial-to-mesenchymal transition (EMT) is considered …

Abstract Transmembrane TNF-α (tmTNF), a transmembrane form of TNF-α, was reported
overexpressed in approximately 84% of triple-negative breast cancer (TNBC) patients and …

The formation of cyclinD-CDK4/6 complex plays vital roles in the cell cycle transition from G1
phase to S phase which is characterized by vigorous transcription and synthesis. Through …